Novartis to prepare the sale of its Roche stake: Sonntagszeitung

Sun Apr 24, 2016 9:55am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

VIENNA (Reuters) - Drugmaker Novartis (NOVN.S: Quote) aims to dispose of a 13.5 billion Swiss franc ($13.8 billion) stake in its local rival Roche (ROG.S: Quote) and has already hired banks to support the selling process, a Swiss paper reported on Sunday.

The world's biggest prescription drugmaker started building up the stake - worth 33 percent of Roche's voting shares - as a basis for a possible merger more than a decade ago, but the plan never materialized.

Novartis plans to sell the stake in a so-called order book process, having banks collect purchase offers within a predefined price range from selected investors, weekly Sonntagszeitung said, citing board and banking sources.

A Novartis spokesman declined to comment on the report.

(Reporting by Kirsti Knolle; Editing by Alison Williams)

 
The logo of Swiss pharmaceutical company Novartis is seen on its headquarters building in Basel, Switzerland October 27, 2015. REUTERS/Arnd Wiegmann